Pulmonology Clinical Essentials

Mastering the essentials of pulmonary medicine is critical because respiratory complaints are among the most common presentations you will encounter in clinical practice. From chronic conditions like asthma to life-threatening emergencies like massive pulmonary embolism, your ability to accurately diagnose and manage these diseases directly impacts patient survival, quality of life, and healthcare outcomes.

Clinical Assessment of Common Respiratory Diseases

A systematic approach to respiratory disease begins with a focused history and physical exam, which guides your diagnostic and therapeutic decisions. For asthma management, the cornerstone is assessing control. You must distinguish between intermittent and persistent asthma, gauge the frequency of rescue inhaler use, and identify triggers. Management follows a stepwise approach, starting with a short-acting beta-agonist (SABA) for rescue and adding an inhaled corticosteroid (ICS) as first-line maintenance therapy for persistent symptoms. A written asthma action plan is a non-negotiable component of effective management, empowering patients to adjust therapy based on peak flow measurements and symptom zones.

In contrast, Chronic Obstructive Pulmonary Disease (COPD) is characterized by persistent and usually progressive airflow limitation. The history is key: look for a long smoking history, chronic cough, sputum production, and exertional dyspnea. Management focuses on smoking cessation, bronchodilators (long-acting muscarinic antagonists and beta-agonists), pulmonary rehabilitation, and vaccination. However, you must be adept at recognizing and managing COPD exacerbations, defined as an acute worsening of respiratory symptoms. First-line treatment includes intensified bronchodilation, systemic corticosteroids, and antibiotics if there is evidence of bacterial infection (e.g., increased purulent sputum).

Diagnosis and Management of Acute Lung Pathology

Acute respiratory illnesses require rapid, precise intervention. Pneumonia classification and treatment depend largely on where it was acquired. Community-acquired pneumonia (CAP) is treated empirically based on severity, often with a respiratory fluoroquinolone or a beta-lactam plus a macrolide. Use the Pneumonia Severity Index (PSI) or CURB-65 score to decide between outpatient and inpatient management. Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) involve different, more resistant pathogens (like Pseudomonas and MRSA) and require broader-spectrum antibiotics.

A pulmonary embolism (PE) workup is triggered by the classic triad of dyspnea, pleuritic chest pain, and hemoptysis—though many patients present atypically. Your first step is to assess clinical probability using a validated tool like the Wells' Criteria. For likely PE, start with a D-dimer test (if low probability) or proceed directly to CT pulmonary angiography (CTPA), which is the imaging gold standard. Immediate management involves hemodynamic stabilization, anticoagulation (with low molecular weight heparin, fondaparinux, or a direct oral anticoagulant), and assessing for thrombolytic eligibility in massive PE.

Evaluation of Complex Respiratory Syndromes

When a patient presents with dyspnea and chest imaging reveals abnormalities, you must differentiate between fluid, infection, and parenchymal disease. A pleural effusion is identified on chest X-ray or ultrasound. The critical next step is determining if it is a transudate (due to systemic factors like heart failure or cirrhosis) or an exudate (due to local inflammation from pneumonia, malignancy, or PE) using Light's Criteria. Diagnostic thoracentesis is typically required for exudative effusions to guide therapy, which ranges from diuresis for transudates to chest tube drainage or pleurodesis for recurrent malignant effusions.

Interstitial lung disease (ILD) represents a large group of disorders causing inflammation and fibrosis of the lung parenchyma. Patients present with progressive, often insidious dyspnea and a dry cough. Physical exam may reveal fine, Velcro-like crackles on lung auscultation. High-resolution CT (HRCT) scan is the central diagnostic tool, revealing patterns like usual interstitial pneumonia (UIP). Management is complex and disease-specific; for idiopathic pulmonary fibrosis (IPF), antifibrotic agents (pirfenidone, nintedanib) are used, while some forms of ILD may respond to immunosuppressants like corticosteroids.

Interpreting Key Diagnostic Data

Pulmonary function test (PFT) interpretation is a fundamental skill. You must understand the key volumes and flows. The Forced Vital Capacity (FVC) is the total volume exhaled with maximal effort. The Forced Expiratory Volume in 1 second (FEV1) is the volume exhaled in the first second. The FEV1/FVC ratio is the core metric for identifying obstructive versus restrictive defects.

• Obstructive Pattern (e.g., Asthma, COPD): FEV1/FVC ratio is reduced (typically <0.7). The FEV1 is disproportionately reduced compared to FVC. Look for improvement post-bronchodilator to assess reversibility.
• Restrictive Pattern (e.g., ILD, chest wall disease): FEV1/FVC ratio is normal or increased. Both FEV1 and FVC are reduced proportionally. This pattern indicates reduced lung volumes.
• Diffusing Capacity (DLCO): Measures gas exchange across the alveolar-capillary membrane. It is reduced in conditions like ILD, emphysema, and pulmonary vascular disease.

Common Pitfalls

1. Treating all wheeze as asthma: COPD, heart failure ("cardiac asthma"), anaphylaxis, and foreign body aspiration can all cause wheezing. Failing to consider alternatives, especially in an older smoker, leads to mismanagement. Always corroborate the diagnosis with PFTs and a detailed history.
2. Delaying anticoagulation during PE workup: If clinical suspicion is high, you should initiate anticoagulation empirically while awaiting confirmatory imaging (unless strongly contraindicated). Waiting for the CTPA result in a high-risk patient can lead to fatal clot progression.
3. Overusing antibiotics in COPD exacerbations: Antibiotics are only indicated if the patient has increased sputum purulence plus either increased dyspnea or increased sputum volume. Prescribing them for every exacerbation drives antibiotic resistance.
4. Misinterpreting pleural effusions: Assuming a bilateral effusion is always a transudate from heart failure can cause you to miss other causes like malignancy or pulmonary embolism. Always analyze the fluid if the cause is uncertain or if the effusion is unilateral, febrile, or fails to respond to therapy for the presumed cause.

Summary

• Asthma and COPD are common obstructive diseases managed with inhalers, but asthma is reversible and inflammatory, while COPD is progressive and linked to smoking. Recognize and treat exacerbations promptly.
• Pneumonia management is dictated by setting (CAP vs. HAP/VAP) and severity scores (PSI, CURB-65) to guide antibiotic choice and admission decisions.
• Pulmonary embolism requires a probability-based workup (Wells' Criteria, D-dimer, CTPA) and immediate anticoagulation. Consider thrombolysis for massive, hemodynamically unstable PE.
• Pleural effusions require classification into transudate or exudate using Light's Criteria via thoracentesis to direct therapy.
• Interstitial Lung Disease presents with progressive dyspnea and dry cough; diagnosis hinges on HRCT pattern, and management varies from antifibrotics to immunosuppression.
• Pulmonary Function Tests are interpreted by the FEV1/FVC ratio: a low ratio indicates obstruction, while a normal/high ratio with low volumes indicates restriction. DLCO assesses gas exchange.